» Authors » Julie Gastier-Foster

Julie Gastier-Foster

Explore the profile of Julie Gastier-Foster including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 19272
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Voeller J, Katzenstein H, Naranjo A, Tenney S, Chen L, London W, et al.
Pediatr Blood Cancer . 2024 Nov; 72(1):e31407. PMID: 39502014
Background: Tumor invasion of the spinal canal is detected radiographically in approximately 15% of patients with newly diagnosed neuroblastoma (NB). The optimal clinical approach to maintain excellent survival outcomes while...
2.
Barr E, Naranjo A, Twist C, Tenney S, Schmidt M, London W, et al.
Pediatr Blood Cancer . 2024 Jun; 71(8):e31089. PMID: 38822537
Background: We previously reported excellent three-year overall survival (OS) for patients with newly diagnosed intermediate-risk neuroblastoma treated with a biology- and response-based algorithm on the Children's Oncology Group study ANBL0531....
3.
Li Z, Chang T, Junco J, Devidas M, Li Y, Yang W, et al.
Blood . 2023 Mar; 142(2):172-184. PMID: 37001051
Trisomy 21, the genetic cause of Down syndrome (DS), is the most common congenital chromosomal anomaly. It is associated with a 20-fold increased risk of acute lymphoblastic leukemia (ALL) during...
4.
Gupta S, Dai Y, Chen Z, Winestone L, Teachey D, Bona K, et al.
Lancet Haematol . 2023 Feb; 10(2):e129-e141. PMID: 36725118
Background: Previous studies have identified racial and ethnic disparities in childhood acute lymphocytic leukaemia survival. We aimed to establish whether disparities persist in contemporaneous cohorts and, if present, are attributable...
5.
Garcia-Recio S, Hinoue T, Wheeler G, Kelly B, Garrido-Castro A, Pascual T, et al.
Nat Cancer . 2022 Dec; 4(1):128-147. PMID: 36585450
The AURORA US Metastasis Project was established with the goal to identify molecular features associated with metastasis. We assayed 55 females with metastatic breast cancer (51 primary cancers and 102...
6.
Brady S, Roberts K, Gu Z, Shi L, Pounds S, Pei D, et al.
Nat Genet . 2022 Sep; 54(9):1376-1389. PMID: 36050548
Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. Here, using whole-genome, exome and transcriptome sequencing of 2,754 childhood patients with ALL, we find that, despite a generally low...
7.
Yang H, Zhang H, Luan Y, Liu T, Yang W, Roberts K, et al.
Nat Genet . 2022 Feb; 54(2):170-179. PMID: 35115686
Inherited noncoding genetic variants confer significant disease susceptibility to childhood acute lymphoblastic leukemia (ALL) but the molecular processes linking germline polymorphisms with somatic lesions in this cancer are poorly understood....
8.
Wheeler D, Takebe N, Hinoue T, Hoadley K, Cardenas M, Hamilton A, et al.
Cancer Cell . 2020 Nov; 39(1):38-53.e7. PMID: 33217343
A small fraction of cancer patients with advanced disease survive significantly longer than patients with clinically comparable tumors. Molecular mechanisms for exceptional responses to therapy have been identified by genomic...
9.
Hingorani P, Dinu V, Zhang X, Lei H, Shern J, Park J, et al.
Sci Rep . 2020 Jul; 10(1):12318. PMID: 32703985
To further understand the molecular pathogenesis of desmoplastic small round cell tumor (DSRCT), a fatal malignancy occurring primarily in adolescent/young adult males, we used next-generation RNA sequencing to investigate the...
10.
Conley B, Staudt L, Takebe N, Wheeler D, Wang L, Cardenas M, et al.
J Natl Cancer Inst . 2020 Apr; 113(1):27-37. PMID: 32339229
Background: Tumor molecular profiling from patients experiencing exceptional responses to systemic therapy may provide insights into cancer biology and improve treatment tailoring. This pilot study evaluates the feasibility of identifying...